AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (1.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Clinical Research | Publishing Language: Chinese | Open Access

Clinical features of CRLF2 overexpression in pediatric B-cell acute lymphoblastic leukemia

Yi-Yu WANG, Juan WEI, Yan ZHOU, Li LIU, Xin TIAN( )
Department of Hematology, Sichuan Provincial Maternity and Child Health Care Hospital, Chengdu 610032, China
Show Author Information

Abstract

Objective

To study the clinical features and prognostic impact of CRLF2 overexpression in children with B-cell acute lymphoblastic leukemia (B-ALL).

Methods

A retrospective study included pediatric B-ALL patients admitted to Sichuan Provincial Maternity and Child Health Care Hospital and Kunming Children's Hospital from October 2018 to October 2022. Patients were divided into a CRLF2 overexpression group and a control group without CRLF2 overexpression according to CRLF2 gene testing at initial diagnosis. Clinical features and prognosis between groups were compared.

Results

A total of 93 children with B-ALL were enrolled, including 29 with CRLF2 overexpression. The age of onset ranged from 2 to 12 years. At diagnosis, the proportions of hepatosplenomegaly and thrombocytopenia in the CRLF2 overexpression group were significantly lower than those in the control group (P<0.05), while the proportion of masses was significantly higher (P<0.05). Significantly higher CRLF2 protein expression in the CRLF2 overexpression group than in the control group (P<0.05). The mean 3-year event-free survival (EFS) and overall survival (OS) rates in the CRLF2 overexpression group were 75.9% and 85.9%, respectively, lower than the control group (90.1% and 91.0%, respectively), but the differences lacked statistical significance by log-rank test.

Conclusions

These findings suggest a potential role of CRLF2 overexpression in disease progression. Further studies with larger sample sizes are warranted to confirm its prognostic significance.

References

【1】
【1】
 
 
Chinese Journal of Contemporary Pediatrics
Pages 832-838

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
WANG Y-Y, WEI J, ZHOU Y, et al. Clinical features of CRLF2 overexpression in pediatric B-cell acute lymphoblastic leukemia. Chinese Journal of Contemporary Pediatrics, 2026, 28(7): 832-838. https://doi.org/10.7499/j.issn.1008-8830.2510146

4

Views

0

Downloads

0

Crossref

0

Scopus

0

CSCD

Received: 31 October 2025
Accepted: 12 June 2026
Published: 15 July 2026
© Editorial Office of Chinese Journal of Contemporary Pediatrics.

OA under CC BY-NC-ND 4.0 license